R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical vascular disease, and erectile dysfunction

被引:15
|
作者
Mostaza, Jose M. [1 ]
Lahoz, Carlos
Salinero-Fort, Miguel A.
de Dios, Olaya
Castillo, Elisa
Gonzalez-Alegre, Teresa
Garcia-Iglesias, Francisca
Estirado, Eva
Laguna, Fernando
Sabin, Concesa
Lopez, Silvia
Cornejo, Victor
de Burgos, Carmen
Sanchez, Vanesa
Garces, Carmen
机构
[1] Hosp Carlos III, Internal Med Dept, Atherosclerosis Unit, Sinesio Delgado 10, Madrid 28029, Spain
关键词
Ankle-brachial index; Carotid atherosclerosis; Erectile dysfunction; Intima-media thickness; LDL-cholesterol; PCSK9; R46L; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; LDL CHOLESTEROL; RISK; PLASMA; VARIANTS; INDEX;
D O I
10.1016/j.jacl.2018.04.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: The R46L variant of the proprotein convertase subtilisin/kexin type 9 (PCSK9) gene has been related to lipid levels and cardiovascular disease. OBJECTIVE: To evaluate the influence of this polymorphism on subclinical vascular disease and erectile dysfunction (ED). METHODS: We analyzed the association of the PCSK9 rs11591147 single-nucleotide polymorphism with lipid levels, intima-media thickness (IMT), and the ankle-brachial index, in 1188 adults free of cardiovascular disease, randomly selected from the population. In 473 male participants, we also investigated its relationship with ED. The association of the R46L polymorphism with lipid levels was also assessed in 2 cohorts of 1103 prepuberal children and 830 adolescents. RESULTS: The prevalence of the T allele was 2.9% in adults. Low-density lipoprotein cholesterol (LDL-cholesterol) levels did not vary according to this polymorphism (134 +/- 32 vs 134 +/- 31 mg/dL, for the TT + GT vs GG carriers, respectively, P = .931). Despite equal LDL-cholesterol levels, adults carrying the T allele had a lower mean common carotid IMT (0.685 +/- 0.09 vs 0.723 +/- 0.127 mm; P = .035), a lower maximum common carotid IMT (0.819 +/- 0.11 vs 0.865 +/- 0.159 mm; P = .040), and, in males, a lower prevalence of ED (36.8% vs 61%: P = .036), than GG carriers. Prevalence of the T allele was 3.2% in both cohorts of children. They had lower levels of LDL-cholesterol than GG subjects (100 vs 109 mg/dL; P = .060, for prepuberal children, and 85 vs 99 mg/dL; P = .010 for adolescents). CONCLUSION: In our population, an association between the PCSK9 R46L variant and LDL-cholesterol levels is observed in children. In adults, although its association with lipid levels is not evident, there is a significant relationship between the PCSK9 R46L variant and markers of subclinical atherosclerosis, including IMT and ED. (C) 2018 National Lipid Association. All rights reserved.
引用
收藏
页码:1039 / 1046
页数:8
相关论文
共 50 条
  • [1] THE R46L POLYMORPHISM OF PCSK9 GENE AND LIPID PROFILE IN CAUCASIAN POPULATION OF RUSSIA
    Astrakova, K.
    Shakhtshneider, E.
    Ivanoshchuk, D.
    Ragino, Y.
    Astrakov, S.
    Voevoda, M.
    ATHEROSCLEROSIS, 2016, 252 : E40 - E40
  • [2] The R46L variant in the PCSK9 gene is associated with plasma lipid levels and lower cardiovascular risk in UK men
    Scartezini, M.
    Whittall, R. A.
    Cooper, J. A.
    Humphries, S. E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 49 - 49
  • [3] The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy UK men
    Scartezini, Marileia
    Hubbart, Christina
    Whittall, Ros A.
    Cooper, Jackie A.
    Neil, Andrew H. W.
    Humphries, Steve E.
    CLINICAL SCIENCE, 2007, 113 (11-12) : 435 - 441
  • [4] THE PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) R46L GENE POLYMORPHISM AND STATIN RESPONSE IN A TUNISIAN CORONARY ATERY DISEASE POPULATION
    Kallel, A.
    Omar, S.
    Ben Achour, W.
    Sbai, M.
    Mechmeche, R.
    Jemaa, R.
    Kaabachi, N.
    ATHEROSCLEROSIS, 2015, 241 (01) : E206 - E206
  • [6] The Effects of the PCSK9 R46L Genetic Variant on the Human Plasma Proteome
    Benson, Mark
    Yang, Qiong
    Ngo, Debby
    Zhang, Ruibo
    Shen, Dongxiao
    Sinha, Sumita
    Farrell, Laurie
    Ramachandran, Vasan S.
    Larson, Martin
    Wang, Thomas J.
    Gerszten, Robert E.
    CIRCULATION, 2019, 140
  • [7] REGIONAL DISTRIBUTION AND METABOLIC IMPACT OF PCSK9 INSLEU AND R46L GENE MUTATIONS AND APOE GENOTYPE
    Awan, Z.
    Awan, A.
    Delvin, E. E.
    Levy, E.
    Genest, J.
    Davignon, J.
    Seidah, N. G.
    Baass, A.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S164 - S164
  • [8] Regional Distribution and Metabolic Effect of PCSK9 insLEU and R46L Gene Mutations and apoE Genotype
    Awan, Zuhier
    Delvin, Edgard E.
    Levy, Emile
    Genest, Jacques
    Davignon, Jean
    Seidah, Nabil G.
    Baass, Alexis
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (08) : 927 - 933
  • [9] PCSK9 GENETIC VARIANT R46L IN A SPANISH POPULATION WITH MODERATE-HIGH CARDIOVASCULAR RISK
    Rey-Zamora, D.
    Fabregate-Fuente, R.
    Fabregate-Fuente, M.
    Tello-Blasco, S.
    Barrio-Carreras, D.
    Rodriguez-Guerrero, A.
    Reyes-Valdivia, A.
    Palomino-Antolin, A.
    Clemente-Vargas, I.
    Olariaga-Merida, E.
    Diaz-Dominguez, C.
    Saban-Ruiz, J.
    ATHEROSCLEROSIS, 2015, 241 (01) : E131 - E131
  • [10] Loss-of-function mutation R46L in the PCSK9 gene has little impact on the levels of total serum cholesterol in familial hypercholesterolemia heterozygotes
    Strom, Thea Bismo
    Holla, Oystein L.
    Cameron, Jamie
    Berge, Knut Erik
    Leren, Trond P.
    CLINICA CHIMICA ACTA, 2010, 411 (3-4) : 229 - 233